Portrait No. 001
Ana Rita Moreira
President and Co-Founder
v-ATPase Alliance
Raised — Currently in a raise
I founded the v-ATPase Alliance in the wake of the inconceivable. When my firstborn was diagnosed with an ultra-rare genetic disorder, I was handed a void: no answers, no treatment, and no path forward. As a mother, I refused to accept that my son’s life was a scientific dead end. I pivoted from corporate strategy to life-saving architecture, building a global organization where none existed. We are the only entity in the world dedicated to the v-ATPase-related diseases - the master regulator of cellular life. We are unique because we don't just advocate; we engineer. By mapping this protein, we aren't just saving a few children; we are unlocking the secrets of autophagy for major killers like Cancer and Alzheimer’s. I am not just a founder; I am the architect of a bridge across a scientific abyss; and my why is that my son is 1 in 27 affected by this ultra-rare genetic disease.
In her words
“I am a creative troublemaker whose leadership was built from the silence of a medical void after my son's ultra-rare genetic diagnosis. I turned the wreckage of a past life into a mission to rewrite the future of this rare disease and beyond.”
Chapter I
The toughest challenges you've faced as a founder.
Building a global biotech-adjacent research powerhouse from a hospital bedside is a masterclass in defiance. As a woman, a mother, and a founder, I’ve had to be twice as fast and ten times as bold, possessing the audacity to convince world-class scientists to pivot their focus to our cause. I’ve faced the silent bias of being \"just a mother,\" but I’ve used it as my greatest weapon: a mother’s urgency is the most efficient engine for innovation. The traction proves it. In just one year, we launched a global Patient Registry with RARE-X; for 2025, we are already de-risking the therapeutic pathway through bio-sampling and disease modeling. In these two years of existence, recognition has come rapidly: from the Milken Institute inviting me to keynote the final day of their flagship Future Health Summit, to an invitation from the Galien Foundation as a \"Lived Experience Expert.\" I currently serve as Chair of the largest Rare Epilepsy Network in the world and was invited by the International Bureau for Epilepsy to be one of twenty global leaders defining the strategic plan for Global Epilepsy. Although I am running a non-profit, I lead it as a high-stakes startup that operates on the fuel of unconditional love and the precision of elite science. We aren't just climbing; we are moving the mountain.
Chapter II
Your vision.
I am obsessed with killing the word \"untreatable.\" I want to dismantle the arrogance of a medical system that leaves families in the dark because a condition is \"too rare\" to be profitable. The v-ATPase Alliance will enable a world where patients are the primary architects of their own cures, not just passive observers of their decline. By solving the v-ATPase puzzle, we will provide the key to regulating cellular health and longevity for the entire human race. My vision is to prove that the most \"neglected\" corners of biology actually hold the blueprint for the next century of medical breakthroughs. I want to change the world so that no parent ever has to hear \"there is nothing we can do.\" We are redefining the boundaries of what is medically possible, one proton at a time. Driven by love. Determined to cure.
Chapter III
The impact you want to leave behind — for your industry, your community, and the women who come next.
Thirty years from now, I will be proud to have proven that the \"rare\" was actually the universal blueprint. I want to leave behind an industry that no longer siloes rare diseases, but sees them as the frontier of human longevity. For women, I want my journey to prove that motherhood is a strategic superpower, capable of re-architecting global science from the bedside up. We are unstoppable.